永安药业参股公司黄冈日化拟被其全资子公司天安日化吸收合并

Core Viewpoint - Yong'an Pharmaceutical (002365.SZ) announced the absorption merger of its affiliate Huanggang Yong'an Daily Chemical Co., Ltd. by its wholly-owned subsidiary Hubei Tian'an Daily Chemical Co., Ltd. This merger aims to integrate resources, improve efficiency, and reduce costs [1] Group 1: Merger Details - The merger will not involve any cash payments, and shareholders of Huanggang Daily Chemical will exchange their shares for direct equity in Tian'an Daily Chemical [1] - After the merger, Huanggang Daily Chemical will be dissolved, and all its assets, liabilities, and equity will be legally inherited by Tian'an Daily Chemical [1] - The company's previous investment of 30 million yuan in Huanggang Daily Chemical will convert into a direct investment in Tian'an Daily Chemical, maintaining a shareholding ratio of 6.5217% [1] Group 2: Strategic Implications - The merger is expected to optimize the management structure of the affiliate, reduce management costs, and enhance decision-making efficiency [1] - This move aligns with the overall development strategy of the company, aiming to fully leverage the economic benefits of asset integration [1]